In order to investigate further possible structural differences among the two subgroups of respiratory syncytial virus (RSV), we analysed the antigenic characteristics and size of structural proteins of 20 subgroup A and 43 subgroup B strains by their reactions with monoclonal antibodies (MAbs) directed against the proteins of RSV using immunofluorescence, ELISA and radioimmunoprecipitation assays. The latter test also enabled determination of the size of different structural components. The 37 MAbs employed were generated by immunization with both subgroup A and B strains. They represented specificities for distinct epitopes on five different structural proteins. The subgroup A strains proved to be relatively uniform. The fusion (F) protein, nucleoprotein (NP) and matrix (M) proteins of all strains tested had the same Mr and all except one strain had a phosphoprotein (P protein) of the same Mr. The F and P proteins were lower in Mr in B strains compared to A strains, which confirmed previous findings. The Mr of the large surface glycoprotein (G protein) of subgroup A strains varied slightly, probably on the basis of differing glycosylation. By contrast, the subgroup B strains exhibited substantial variation in the Mr of the G and also the P proteins and in reactivity with MAbs directed against the G and F proteins. Three size classes of the P protein were identified in B strains: 33K to 34K, 32K to 33K, and 31K to 32K. Twenty-seven subgroup B strains failed to react with four anti-G MAbs representing a single epitope, G2; the remaining 16 strains reacted with these MAbs. We designated these two sets of variants of B strains B 1, which lacked the epitope, and B2, which had the epitope. The B1 strains also varied in the size of the G and P proteins. In contrast, all B2 strains had large G proteins and all except two strains had relatively large P proteins (33K to 34K). All subgroup B1 and B2 strains exhibited the same sizes of NP, F and M proteins. We conclude that the subgroup B strains of RSV include two variants, B 1 and B2, and that the major difference between them resides in the G and P proteins.
INTRODUCTION
Respiratory syncytial virus (RSV) belongs to the genus pneumovirus, a subgroup of the Paramyxoviridae. It is the most common cause of severe lower respiratory infections among infants and children, especially those between 2 and 6 months of age (Belshe et al., 1984) . First isolated from a child in 1957 (Chanock et al., 1957) , RSV was considered at first to have only one strain. A few years later, cross-neutralization tests with animal hyperimmune sera revealed slight antigenic differences among a few strains (Coates et al., 1963; Wulff & Wenner, 1964; Doggett & Taylor-Robinson, 1964) . The application of monoclonal technology to antigenic analysis of RSV permitted the recognition of two subgroups, A and B, based on their reactivity with a panel of monoclonal antibodies (MAbs) (Anderson et al., 1985; Mufson et al., 1985; Gimenez et al., 1986) .
The major difference between subgroup A and B strains was found in the large surface glycoprotein (G protein) which probably mediates attachment of the virus to the host cell (Gimenez et al., 1986; Mufson et al., 1985) . Johnson et al. (1987) recently showed that the antigenic relatedness between the G proteins of the two subgroups was only about 5 9/0, whereas the relatedness between the fusion (F) proteins of the two subgroups was nearly 50~. Norrby et al. (1986) employed SDS-PAGE under reducing and non-reducing conditions to demonstrate that the variation in size of the G proteins did not correlate with the virus subgroup, but that it was strain-specific. Furthermore, these investigators also showed that differences in the size of the phosphoprotein (P protein) and the FI cleavage product of the F protein were specific for the two subgroups.
Several investigators from different countries have reported that the two subgroups of RSV co-circulate within the same community (Hendry et al., 1986; Akerlind & Norrby, 1986; Storch & Park, 1987; Mufson et al., 1988) , and that both temporal and geographical clustering of the subgroups could be distinguished (Hendry et al., 1986; Mufson et al., 1988) .
Our intention was to determine whether the strains belonging to subgroups A and B of RSV constitute two homogeneous subgroups. We examined 20 subgroup A and 43 subgroup B strains in order to search for antigenic and structural differences, employing immunofluoresence (IF) tests, ELISA and the radioimmunoprecipitation assay (RIPA).
METHODS

Viruses.
The virus strains consisted of one prototype and 26 field strains of subgroup B1, one prototype and 15 field strains of subgroup B2 and one prototype and 19 field strains of subgroup A (Table 1) . Thirty of the subgroup B strains were obtained from patients tested in Huntington, West Virginia, U.S.A. during the period 1979 to 1986. These strains were isolated from throat swab specimens and were frozen at -70 °C. They were reisolated in HEp-2 ceils and then passaged two or three times in either Vero or HEp-2 cells before use. Eight strains of subgroup B were from people in Stockholm, Sweden; one was obtained in 1971, one in 1979 and six in 1984. They were isolated from throat swab specimens and passaged in Vero cells and stored at -70 °C before use. Two subgroup B isolates originated in Bristol, U.K. during the 1983 to 1984 epidemic year and were provided by Dr E. J. Stott, Institute for Animal Health, Compton, Newbury, U.K. These were passaged three to four times in HEp-2 or HeLa cells and then two to three times in Vero cells before use.
The prototype BI strain was CH18537, isolated in the U.S.A. (Coates et al., 1963) , obtained from Dr R. M. Chanock, NIAID, National Institutes of Health, Bethesda, Md., U.S.A. The prototype B2 strain, WV4843, was isolated from a child in Hungtington during the 1980 to 1981 epidemic year (Mufson et al., 1985) .
Sixteen of the A strains were isolated in Huntington between 1979 and 1985 and were handled in the same manner as described for the subgroup B strains. Two A strains came from Bristol, and were provided by Dr E. J. Stott; these were isolated during the 1983 to 1984 epidemic season and were treated in the same way as the B strains from the U.K. The prototype A strain was the A2 strain originally isolated in Australia in 1961.
Cells. HeLa and Vero cells were grown in Eagle's MEM supplemented with 3 ~ foetal calf serum (FCS), which had been inactivated by heating at 56 °C for 30 min. Virus strains were added when the cells covered 70~ of the culture surface. The medium was then changed to Eagle's MEM containing 0.5~ FCS. When the virus strains grew slowly the 0-5~ medium was changed nearly every day until harvest.
MAbs. The antibodies used were generated from different fusions. They represented specificities for the large glycoprotein G, fusion glycoprotein F, matrix (M) protein, NP, and P protein. The first group of MAbs was produced in the laboratory using the Long strain of RSV, a prototype strain of subgroup A. This panel of MAbs has been described previously (Mufson et al., 1985) . The following antibodies from that panel were used in our tests: anti-G antibodies for six epitopes, G1 C793, G2 B14, B18 and B23, G3 B109 and B158, G4 B17, G5 B25, and G6 B 119; anti-F antibody for one epitope, F 1 B46; anti-M antibody for one epitope, M 1 C781 ; anti-NP antibodies for one epitope, NP1 C797 and B90; anti-P antibody for one epitope, PI C771. Other anti-P-specific MAbs used were M 189, which we prepared, L2, kindly provided by Dr E. E. Walsh, Department of Medicine, The Rochester General Hospital and the University of Rochester School of Medicine and Dentistry, Rochester, New York, U.S. A. and 2B9, 3 H 102, 2F 111, 2G 122 , kindly provided by Dr G. L. Toms, Department of Virology, University of Newcastle upon Tyne, U.K. They were all generated using subgroup A strains of RSV. Epitope specificity was not determined for M 189 or for the MAbs provided for our use by other investigators. A second large group of MAbs was produced in the laboratory using RSV WV4843, subgroup B strain first isolated in Hur~tington 1981 ~() rveil et al., 1987) . The following antibodies from this collection were used: anti-G specific for two epitopes, G1 8188, 8305, 9177 and 9273, and G2 8180, 9244, 9637 and 9794 ; anti-F antibody specific for two epitopes, F1 7858 and 7859, and F4 8239; anti-M antibody specific for one epitope, M2 8085; anti-P antibody specific for three epitopes, P1 8268, P2 9178, and P3 9516 (Table 2 ). Additional anti-P MAbs generated against a subgroup B strain 1960 1961 1963 1970 to 1971 1978 1978 to 1979 1978 to 1979 1978to 1979 1979to1980 1979 to 1980 1980to1981 1980 to 1981 1981 to1982 1981to1982 1982 to 1983 1982to1983 1982 to 1983 1983to1984 1983to1984 1983to1984 1983to1984 1984to1985 1984to 1985 1985 to 1986 1985 to 1986 2147 Origin Subgroup t See Gimenez et al. (1984) .
:~ Epitope specificity not determined.
were 3-5 and 4-14 ( (Norrby et al., 1982) . Veto cells were grown on sterile slides in Eagle's MEM containing 3 ~ FCS. When the cells covered about 70~ of the surface of the slide, the virus was added. The medium was changed to Eagle's MEM with 0.5 ~ FCS. After a few more days of cell growth, the cells completely covered the slide and the c.p.e, involved most of the cell monolayer. The slides were fixed in acetone at -20 °C for l0 min, air-dried and stored at -70 °C until use.
For the assay, the slides were washed in phosphate-buffered saline (PBS) before addition of mouse ascites fluid containing MAbs at a dilution of 1/50. The MAb solution was incubated on the slides for 20 min in a moist chamber at room temperature. After washing three times in PBS, fluorescein-conjugated goat anti-mouse IgG F(ab') 2 fragment (Cappel Laboratories) at a dilution of 1/20 was added and left on for 20 min in a moist chamber at room temperature. Finally, the slides were washed three times in PBS. They were examined using a u.v. microscope with an extinction filter.
ELISA. The procedure for the ELISA has been described in detail (Mufson et al., 1988) . HEp-2 cells grown in plastic flasks were infected with the appropriate RSV strains and harvested when about 50 ~ of the cell monolayer showed c.p.e. The cells were washed twice in PBS, dispensed into microtitre plates at a concentration of 50000 cells per well, and air-dried. Dilutions of MAbs were dispensed into the appropriate wells and allowed to react overnight at 4 °C, washed fully and peroxidase-conjugated rabbit anti-mouse IgG (Dako Laboratories, Santa Barbara, Ca., U.S.A.) was added. After incubation at room temperature for 30 min the plates were washed, 5-aminosalicylate substrate was added to each well, and the plates were incubated for a further 30 min at 37 °C. The colour that developed was quantified in a spectrophotometer. Absorbance values of > 0.2 or, when the background values were slightly elevated, at least three times the average background value of the control wells were considered positive. Control wells contained two sets of infected cells dispensed as for test wells, one set without the addition of MAb and the other without the addition of MAb and conjugate.
RIPA. The technique has been described in detail (Orvell & Norrby, 1980; Sheshberadaran et al., 1983) . Veto and HeLa cells were grown in small plastic flasks and 2 to 6 days after infection, when the c. 
RESULTS
Reactions of virus strains with MAbs in ELISA and IF tests
All 20 subgroup A strains reacted in ELISA and IF tests with the MAbs generated against subgroup A strains, as previously described (Mufson et al., 1985) . Subgroup A strains were positive in IF with all additional anti-P MAbs generated against subgroup A and they were also positive with one anti-P MAb generated against subgroup B. By contrast, none of the subgroup A strains were positive with any of the MAbs directed against subgroup B for the G 1, G2 (Table  3) , F1 and F4 epitopes. All subgroup A strains did react with one anti-M antibody to epitope M2 in ELISA. Anti-P antibodies generated against a subgroup B strain were not employed in ELISA against subgroup A strains.
On the basis of reactivity with the MAbs for the two G epitopes, the 43 subgroup B strains could be divided into two distinct and separate sets, designated B1 and B2 (Table 3 ). The first set included 27 subgroup B strains which failed to react with MAbs to the G2 epitope, namely anti-G2 antibodies 8180, 9244, 9637 and 9794. However, they were positive with the remainder of the MAbs.
The second set, the B2 strains, consisted of 16 strains which were isolated in Huntington; one strain was isolated in 1979 and the other 15 in the 1980 to 1981 epidemic year. All B2 strains reacted with the MAbs to both G epitopes and the F1, M2 and P epitopes. Only one MAb did not react the same way in ELISA and IF. Seven of the 14 subgroup B2 strains failed to react in 
Size of structural proteins
All 20 subgroup A strains had the same size M and F proteins. The G protein varied slightly and this variation appeared to be strain-specific rather than a unique characteristic of subgroup A. The individual size variation probably results from a difference in glycosylation . The P protein of all but one subgroup A strains had an Mr of 36K; strain WV17344 had an Mr of 31K to 32K (Fig. 1) .
The G protein of subgroup B1 strains varied widely in Mr (Table 4 ). The largest G protein had an Mr of 92K to 95K, similar to that of the subgroup A strains, and the smallest was 81K to 84K (Fig. 2) . All the subgroup B2 strains had large G proteins of 92K to 95K. All the subgroup B strains had similar size F and M proteins, as previously described . The F protein of the subgroup B strains, however, was slightly smaller than the F protein of the subgroup A strains .
The P protein of the subgroup B 1 strains was of three distinct sizes: 31K to 32K, 32K to 33K and 33K to 34K (Table 5 ). The three strains with the smallest P protein, namely SW8/60, isolated in 1960 SWF82618, isolated in 1971 (Fig. 3) and CH18537 (not shown), isolated in Washington, D.C., U.S.A. in 1963, were the oldest strains of the 43 subgroup B strains tested. These three subgroup B1 strains also had small G proteins (81K to 84K). None of the other subgroup BI strains had both small G and small P proteins. Other subgroup B1 strains had (1984) . The MAb used was 8268, which is specific for the P protein but coprecipitated the NP. Controls run with non-infected HeLa cells did not show any bands. The smallest bands seen migrating were therefore thought to represent P protein breakdown products. That they were also different sizes supports this idea. WV9894 (1983) ; lane 12, Mr marker proteins. Virus strains WV1293, WV5466 and WV5104 are designated B2 and the strains SW8/60, and SWF82618 are designated B1. The MAb used was M 189, which is specific for the P protein but coprecipitated the NP protein. Controls run with noninfected HeLa cells did not show any bands. The smallest bands were therefore thought to represent P protein breakdown products. That they were also different sizes supports this idea.
medium and large P proteins, either 32K to 33K or 33K to 34K; these strains appeared in the same years and at the same time. All subgroup B2 strains, except two, WV5104 and WV5315, had a P protein of Mr 33K to 34K. WV5104 and WV5315 which were isolated in Huntington in the 1980 to 1981 epidemic year had smaller P proteins of Mr 32K to 33K. All B2 strains, except one, were isolated in Huntington during a single epidemic year, 1980 year, to 1981 .
DISCUSSION
These studies provide evidence that the subgroup B strains of RSV represent a heterogeneous group of viruses. The reactivity of subgroup B strains with M A b s generated using a subgroup B strain provided a basis for categorizing these strains into two distinct sets of variants, which we have designated subgroup B1 and subgroup B2. Our first panel of MAbs, which was generated against a prototype A strain of RSV, enabled differentiation of RSV into two distinct subgroups, namely A and B (Mufson et al., 1985 ; Norrby et al., 1986) . As these were made using a subgroup A strain they did not reveal differences in the B strains whereas those raised against a subgroup B strain did. Subgroup B1 strains differed from B2 strains only in the G2 epitope of the G protein. Thus, the subgroup B1 strains failed to react with the four MAbs specific for this site, while all subgroup B2 strains reacted with them in ELISA, IF and RIPA.
Although all subgroup B1 strains consistently failed to react with MAbs to the G2 epitope, they were not a homogeneous group, as illustrated by the differences in the Mr values of their G and P proteins, which varied widely. Most of the subgroup B 1 strains had G proteins of a medium size, although the Mr of this protein varied between 81K to 84K and 92K to 95K among individual strains. The P protein of the subgroup B1 strains also varied; however, most were 33K to 34K. Three subgroup B1 strains had comparatively small P proteins and these strains were the oldest available in our collection, dating from the 1960s and early 1970s. This finding suggests that the subgroup B1 virus either has undergone systematic genetic alterations or that the strains with small P proteins circulate infrequently in the community. The three strains with the smallest G protein also had the smallest P protein, but otherwise there was no relationship between the sizes of the G and P proteins among the group of subgroup B1 strains tested.
Subgroup B2 strains also varied in the size of the structural components, but not as widely as the strains of subgroup B 1. Unlike the B 1 strains, the G protein of the B2 strains was invariably large (92K to 95K) and similar in size to the G protein among all subgroup A strains. By contrast, the size of the P protein varied slightly among the subgroup B2 strains. All except two of the 16 strains had P proteins of Mr 33K to 34K; these two exceptions (WV5104 and WV5315) had an Mr of 32K to 33K. All B2 strains, except one (WV1293), were isolated during one epidemic year, 1980 to 1981 .
Subgroup B2 strains also differed at the F4 epitope; only half of the strains were reactive in ELISA at this site. There was no difference in reactivity at this site when the strains were tested by IF. Whether they were positive for this epitope or not was unrelated to the Mr of their P protein.
The recognition of subgroups B1 and B2 has implications for understanding the epidemiology of RSV and possibly for the immune response and repeated infections. In temperate climates subgroup B1 strains occur annually in the community and reappear each year after being undetectable during the summer. The subgroup B2 strains predominated in only a single season; they have not been detected in any epidemic year since the 1980 to 1981 season in Hungington. It is likely that the B2 strains represented an isolated antigenic variation in the virus, and that this variant was spread throughout the community and disappeared at the end of the epidemic season.
Whether the subtle antigenic differences between subgroups B1 and B2 of RSV have significance for immunity to RSV B infections remains debatable. Additional data are needed on these strains before their importance in the immunology of RSV infection can be established. Maternal antibodies to RSV protect children from infection, although they do attenuate the severity of the illness; children become reinfected quite easily (Belshe et al., 1984; Henderson et al., 1979) . Mufson et al. (1987) studied immunity among 13 children with repeated RSV infections occurring within 1 year. They found that infection with subgroup A strains of RSV provided some protection from a second infection with the homologous but not the heterologous subgroup of the virus. Unfortunately the number of isolates was small, especially the primary subgroup B infections. Thus, it was not possible to examine the immunity to other RSV infections following an initial subgroup B infection.
Our results also support the concept that RSV subgroup A comprises a nearly homogeneous subgroup. The reaction pattern with the MAbs in the IF test was uniform. The G protein differed very slightly in Mr between different strains, probably because of variable degrees of glycosylation.
It is not clear whether the differences among the subgroup B strains are of importance for efforts in producing a vaccine against RSV infections. Also, differences among subgroup B strains can serve as epidemiological markers. Morgan et al. (1987) have reported different reaction patterns within the subgroup A strains involving subgroup A-specific MAbs to the G and to the 22K proteins. They noticed that different strains belonging to subgroup B had different sizes of the P protein. They detected only two different sizes of the P protein, 31K and 33K to 34K. The only strain having the 31K P protein was isolated in 1965 and this finding correlates well with our results; the three strains of ours with the smallest P protein were isolated between 1960 and 197t.
